Cornering metastases: therapeutic targeting of circulating tumor cells and stem cells
Author:
Open Access
- 1 January 2012
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 2, 30967
Abstract
The last decade has witnessed an evolution of our understanding of the biology of the metastatic cascade. Recent insights into the metastatic process show that it is complex, dynamic, and multi-directional. This process starts at a very early stage in the natural history of solid tumor growth leading to early development of metastases that grow in parallel with the primary tumor. The role of stem cells in perpetuating cancer metastases is increasingly becoming more evident. At the same time, there is a growing recognition of the crucial role circulating tumor cells (CTCs) play in the development of metastases. These insights have laid the biological foundations for therapeutic targeting of CTCs, a promising area of research that aims to reduce cancer morbidity and mortality by preventing the development of metastases at a very early stage. The hematogenous transport phase of the metastatic cascade provides critical access to CTCs for therapeutic targeting aiming to interrupt the metastatic process. Recent advances in the fields of nanotechnology and microfluidics have led to the development of several devices for in vivo targeting of CTC during transit in the circulation. Selectin-coated tubes that target cell adhesion molecules, immuno-magnetic separators, and in vivo photo-acoustic flow cytometers are currently being developed for this purpose. On the pharmacological front, several pharmacological and immunological agents targeting cancer stem cells are currently being developed. Such agents may ultimately prove to be effective against circulating tumor stem cells (CTSCs). Although still in its infancy, therapeutic targeting of CTCs and CTSCs offers an unprecedented opportunity to prevent the development of metastasis and potentially alter the natural history of cancer. By rendering cancer a “local” disease, these approaches could lead to major reductions in metastasis-related morbidity and mortality.Keywords
This publication has 49 references indexed in Scilit:
- Circulating tumour cells, their role in metastasis and their clinical utility in lung cancerLung Cancer, 2012
- Targeting Tumor-Initiating Cancer Cells with dCD133KDEL Shows Impressive Tumor Reductions in a Xenotransplant Model of Human Head and Neck CancerMolecular Cancer Therapeutics, 2011
- Circulating tumor cells in breast cancer: A tool whose time has come of ageBMC Medicine, 2011
- Do all roads lead to Rome? Routes to metastasis developmentInternational Journal of Cancer, 2011
- A Perspective on Cancer Cell MetastasisScience, 2011
- Targeted Removal of Migratory Tumor Cells by Functionalized Magnetic Nanoparticles Impedes Metastasis and Tumor ProgressionNanomedicine, 2010
- Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate CancerJournal of Oncology, 2009
- Tumor Self-Seeding by Circulating Cancer CellsCell, 2009
- Circulating tumor cells in gastrointestinal cancerJournal of Hepato-Biliary-Pancreatic Sciences, 2009
- CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cellsInternational Journal of Cancer, 2007